These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8545251)

  • 41. Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD.
    Kohan DE; Padilla E; Hughes AK
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F670-6. PubMed ID: 7694506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelin receptor subtypes in resistance arteries from humans and rats.
    Deng LY; Li JS; Schiffrin EL
    Cardiovasc Res; 1995 Apr; 29(4):532-5. PubMed ID: 7796447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of 125I-endothelin-1 binding to rat and rabbit renal microvasculature.
    Edwards RM; Trizna W
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1084-9. PubMed ID: 7562473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [125I]BQ3020, a novel endothelin agonist selective for the endothelinB receptor subtype.
    Assal AA; Gessner G; Jarvis MF
    Brain Res Brain Res Protoc; 1997 Feb; 1(1):23-6. PubMed ID: 9385043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling.
    Zhu G; Wu LH; Mauzy C; Egloff AM; Mirzadegan T; Chung FZ
    J Cell Biochem; 1992 Oct; 50(2):159-64. PubMed ID: 1429881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
    Wu-Wong JR; Chiou WJ; Dixon DB; Opgenorth TJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S380-4. PubMed ID: 8587421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.
    Rossi G; Albertin G; Belloni A; Zanin L; Biasolo MA; Prayer-Galetti T; Bader M; Nussdorfer GG; Palù G; Pessina AC
    J Clin Invest; 1994 Sep; 94(3):1226-34. PubMed ID: 8083364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of endothelin receptors in rat renal artery in vitro.
    Clark KL; Pierre L
    Br J Pharmacol; 1995 Feb; 114(4):785-90. PubMed ID: 7773538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
    Gellai M; Fletcher T; Pullen M; Nambi P
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LU 302 872 and its racemate (LU 224 332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions.
    Raschack M; Göck S; Unger L; Hahn A; Amberg W; Jansen R; Alken P; Weber A; Hergenröder S
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S241-4. PubMed ID: 9595449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
    Nambi P; Wu HL; Pullen M; Aiyar N; Bryan H; Elliott J
    Mol Pharmacol; 1992 Aug; 42(2):336-9. PubMed ID: 1325032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
    Maguire JJ; Davenport AP
    Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.
    Breu V; Löffler BM; Clozel M
    FEBS Lett; 1993 Nov; 334(2):210-4. PubMed ID: 8224248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutational analysis of human endothelin receptors ETA and ETB identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu).
    Becker A; Haendler B; Hechler U; Schleuning WD
    Eur J Biochem; 1994 May; 221(3):951-8. PubMed ID: 8181477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist-dependent inhibition by peptide and nonpeptide endothelin receptor antagonists in the rabbit isolated pulmonary artery.
    Beck GR; Douglas SA; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S385-8. PubMed ID: 8587422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Douglas SA; Edwards RM; Gellai M; Lago A; Leber JD; Cousins RD; Gao A; Frazee JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8052-6. PubMed ID: 8058755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL; Cody WL; He JX; Flynn MA; Welch KM; Reynolds EE; Doherty AM
    Pept Res; 1993; 6(5):238-41. PubMed ID: 8257799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.